Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options
Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts
Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026
Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd
Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
International Oral Care Leader Announces Year-Long Partnership with International Rescue CommitteeNASHVILLE, Tenn., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, the...
Industry veteran brings deep financial and management expertise to LifeMD as company continues to transform healthcare and build out growing...
Completion of the Study Expected by the End of 2022 FREMONT, CA, Sept. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...
Lowell Smokes initially available at Ascend Friend Street in downtown Boston in advance of statewide launch later this fallSALINAS, Calif.,...
NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (the “Company” or “Better Choice”), an animal...
SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
ISELIN, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch...
STOUGHTON, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being...
Galecto now has three ongoing Phase 2 clinical trials with three different drug candidates in three high value indicationsBOSTON, Sept....
LOS ANGELES, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on...
BROOKLYN, N.Y., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...
NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (“Intercept”), a biopharmaceutical company focused on the development...
CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to...
VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an...
Pro-C3 and ALT reductions point to anti-inflammatory and antifibrotic effects of CRV431PK-PD models successfully predict early reductions in Pro-C3 and...
REHOVOT, Israel, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based...
Spectral Sponsors Live Webinar hosted by its CMO at the Sepsis Alliance Symposium September 13th is World Sepsis Day; September...
FORT LAUDERDALE, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”),...
Trial launch in Europe coincides with the Company’s upcoming presentation at the European Society for Medical Oncology CongressWILMETTE, Ill., Sept....
The Company expands into exploration of its novel signal processing technology in physiologic pacing proceduresWestport, CT, Sept. 13, 2021 (GLOBE...
